Regulation

25 October 2021

National Directory for Radiation Protection (RPS 6) is the uniform national framework for radiation protection in Australia.

6 September 2021

ARPANSA has also commenced an independent environmental monitoring program. The independent measurements obtained by ARPANSA are compared against the values measured by ANSTO. This is done to provide additional assurance that the results reported by ANSTO are accurate and the community and environment are protected from harmful effects of radiation.

Compass for navigating radiation regulation
10 December 2019

How is radiation regulated in Australia? It’s a common question, and unfortunately the answer isn’t as straightforward as it could be.

Clipboard icon with checkbox
6 December 2019

In June 2018, ARPANSA issued a direction to its licence holder, the Australian Nuclear Science and Technology Organisation (ANSTO), to initiate an independent review of its approach to occupational radiation safety at its nuclear medicine facility operated by ANSTO Health, now known as Health Products.

Close up photo of pages in document
25 September 2019

Part of ARPANSA’s role is the regulation of all Commonwealth entities that use radiation. Regulation ensures compliance with the Australian Radiation Protection and Nuclear Safety Act 1998 and associated Regulations (2018) and is supported by a series of regulatory guides.

Close up photo of pages in document
13 December 2018

The ARPANS Regulations 1999 and ARPANS Licence Charges Regulations 2000 have been repealed and replaced.

Image of woman talking to people around a table
18 October 2018

ARPANSA is committed to applying a consistent approach in how it regulates Commonwealth entities.

Clipboard icon with checkbox
12 April 2018

ARPANSA’s CEO, Dr Carl-Magnus Larsson has issued a licence to the Australian Nuclear Science and Technology Organisation (ANSTO) to operate the ANSTO Nuclear Medicine Molybdenum-99 (Mo-99) Facility (the ANM Facility).

Man reading report
27 February 2018

On Monday 26 February 2018 a report by the CEO of ARPANSA, Dr Carl-Magnus Larsson, was tabled in Parliament addressing the radiation exposure of a worker at the Australian Nuclear Science and Technology Organisation (ANSTO) Health radiopharmaceuticals production facility at Lucas Heights.

Man reading report
26 February 2018

The matter considered in this report is a radiation exposure of a worker on 22 August 2017 at the Australian Nuclear Science and Technology Organisation (ANSTO) Health radiopharmaceuticals production facility at Lucas Heights, NSW, which exceeded the relevant statutory dose limit.

Pages

Subscribe to RSS - Regulation